Start here if you're new
what it is
International Paper makes boxes, pulp, and fiber packaging that move your stuff before you ever see it.
how it gets paid
Last year L Paper made $23.6B in revenue.
why it's growing
Revenue grew 293.5% last year. Revenue rose 53% vs. prior year to $6.0B.
what just happened
The last quarter was a miss: EPS came in at -$0.08 versus a $0.25 estimate, even as revenue hit $6.0B.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
30/100 earnings predictability — expect surprises
14.8x trailing p/e — the market's not buying it — or you found a deal
4.8% dividend yield — cash in your pocket every quarter
9.0% return on capital — nothing to write home about
xvary composite: 42/100 — below average
What they do
International Paper makes boxes, pulp, and fiber packaging that move your stuff before you ever see it.
This business wins with steel-toed scale. It runs 15 mills, 159 converting and packaging plants, and 15 recycling plants in the U.S., plus operations across Europe, North Africa, and Latin America. Scale → more plants close to customers → lower freight and steadier supply, so your box supplier is hard to replace when your factory cannot miss a shipment.
How they make money
$23.6B
annual revenue · their business grew +293.5% last year
total revenue
$23.6B
+293.5%
The products that matter
manufactures corrugated packaging
Corrugated Packaging
$23.6B revenue
it's the center of gravity: a $23.6B business that grew 26.9% last year, yet still finished FY2025 at -$0.08 in EPS. scale is the story. clean conversion of that scale into earnings is the missing part.
the whole story
north american packaging operations
North America
$15.0B sales · $2.3B adjusted EBITDA
management wants you to value this as the steadier cash engine. EBITDA means profit before interest, taxes, depreciation, and amortization. In human-speak: this is the piece they think looks cleaner on its own.
cash engine
emea packaging operations
EMEA
$8.5B sales · $800M adjusted EBITDA
this would be a sizable standalone company, not a leftover bin. The catch is that management is asking you to believe separate management and local control will create value faster than added complexity destroys it.
separation bet
Key numbers
$63
18-month target
The published 18-month target is $63 versus $42.89 today, so your upside case is 47% if the split story works.
4.8%
dividend yield
You are being paid 4.8% to wait, which matters when sales growth is projected at only 1.0%.
$8.8B
long-term debt
Debt equals 28% of capital, which is fine in a stable box market and less fun in a downturn.
9.0%
return on capital
Return on capital measures profit on money invested → plain English: how hard the assets work → so what: 9.0% is decent, not elite.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 50 / 100
- long-term debt $8.8B (28% of capital)
- net profit margin 6.7% — keeps 7 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in IP 3 years ago → it's now worth $13,070.
The index would have given you $14,540.
source: institutional data · total return
What just happened
missed estimates
The last quarter was a miss: EPS came in at -$0.08 versus a $0.25 estimate, even as revenue hit $6.0B.
Revenue rose 53% vs. prior year to $6.0B, but earnings did not follow. Quiet part out loud: bigger sales are useless if the company cannot turn them into stable profit.
$6.0B
revenue
$0.08
eps
21.0%
operating margin
the number that mattered
The key number was the 42.86% earnings miss, because it showed how far actual profit still sits from the cleaner turnaround story.
-
international paper has announced a plan to separate operations into two standalone companies.the packaging giant intends to retain its north american business and spin off its european middle eastern african (emea) interests.
-
on the surface, the split would appear to reverse the 2024 acquisition of ds smith.
-
but a closer look is needed.recent measures, including the closure of 20 facilities under the 80/20 strategy (see below), have helped streamline the european operations. also, the company insists that the next step in the journey towards becoming more profitable is to pursue a more flexibile decisionmaking process based on region-specific strategies. while international paper’s north america operations are more integrated, emea has more localized supply/demand dynamics and offers ample room for expansion.
-
both businesses possess strengths.pro forma 2025 results in the north american business are comprised of $15 billion in sales and $2.3 billion in adjusted ebitda, while the same respective metrics within the emea unit approximate $8.5 billion and $800 million. international paper’s north american operations are close to accelerating top-line growth, following progress achieved under the company’s transformation plan.
-
moreover, we are looking for margins to expand and free cash flow growth to accelerate.concurrently, elevated investments in emea are expected to boost balance sheet health and support a growing dividend. while the separation is probably going to take 12-15 months, international paper intends to retain a significant ownership interest.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the big risk is specific, not generic: management is trying to split north america from emea while investors are still waiting for earnings to normalize after the ds smith deal. that is a delicate project in a business with thin room for error.
med
separation execution risk
management is asking you to underwrite a split expected to take 12–15 months while the company is still coming off a major acquisition and just posted -$0.08 in full-year EPS. that is a lot of moving parts for a business the market already doubts.
if the separation drags or the economics look worse once the pieces stand alone, you are left with the same packaging exposure and a smaller credibility reserve.
med
margin repair failing to show up
packaging is a scale business, but it is still a basic industrial product. A 19.5% operating margin turning into a 5.7% net margin tells you costs, utilization, financing, and cleanup charges eat a lot on the way down.
the stock does not need heroic revenue growth. it needs proof that more of each dollar sold reaches shareholders. if that proof does not arrive, the valuation stays stuck in penalty-box territory.
med
dividend comfort masking earnings stress
a 4.8% dividend yield makes the stock feel calmer than the income statement does. yield is cash in your pocket, but it is not a substitute for durable earnings power.
if FY2026 EPS does not recover toward the $1.70 estimate, investors stop calling this a patient turnaround and start asking whether the yield is compensation for permanent messiness.
all three risks hit the same place: the core $23.6B packaging base. there is no separate high-margin segment in this snapshot waiting to rescue the story.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
separation timeline
management says the split could take 12–15 months. if that slips, the rerating story starts to look like a promise with no clock discipline.
metric
fy2026 eps estimate
the current number is $1.70. here’s the thing: this is the easiest line to monitor if you want to know whether the recovery is real or just being narrated.
risk
institutional selling
institutions were net sellers for two straight quarters, including 275 buyers versus 379 sellers in 4q2025. you want that gap closing, not widening.
trend
north america versus emea economics
north america posts $15B in sales and $2.3B in adjusted EBITDA. emea posts $8.5B and $800M. if those numbers start looking stronger apart than together, the strategic case finally has proof.
Analyst rankings
short-term outlook
bottom 5%
momentum score 5 — the lowest rating. in human-speak, analysts think this trails most stocks near term.
risk profile
average
stability score 3 means you are not buying a bunker stock or a disaster. you are buying something in the middle, with very stock-specific execution risk.
chart momentum
below average
technical score 4 says the tape has not bought the repair story yet. price action and management messaging are still arguing.
earnings predictability
30 / 100
low predictability means the next few quarters matter more than usual, because the market does not trust the pattern and neither should you without proof.
source: institutional data
Institutional activity
institutions have been net selling for 2 consecutive quarters — 275 buyers vs. 379 sellers in 4q2025. total institutional holdings: 0.5B shares. net selling for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$34
$92
$43
current price
$63
target midpoint · +47% from current · 3-5yr high: $80 (+85% · 20% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive